TSXV/QPT (TSXV/QPT)

TSX Venture Exchange: TSXV/QPT · CAD

CA$0.02

+0.00 (0.0%)· Recorded snapshot

Market cap	3.4M
Net income (ttm)	4.9M
EPS (ttm)	CA$0.03
Shares out	169.1M
P/E (trailing)	0.7x
Volume	2,000
Beta	-0.46

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): 4.9M
EPS (ttm): CA$0.03
P/E (trailing): 0.7x
Market cap: 3.4M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 11P50 16.8P75 23.9

Trailing P/E0.7

P25 9.9P50 23.3P75 38.5

ROE20

P25 -104.1P50 -30P75 6.7

ROIC-1.7

P25 -55.9P50 -12.1P75 5

Benchmarks · 1M

All TSXV/QPT indicators

Market & fundamental data

Available fields

156

Groups with data

Currency

CAD

Showing 156 of 156 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-12-18
Enterprise value	CAD 4.3M
Exchange	TSX Venture Exchange
Financial currency	CAD
Financial report date	2026-07-31
First seen	2026-05-10
Fiscal year end	January
Industry	Biotechnology
Is primary listing	Yes
ISIN number	CA74836M1068
Last earnings date	2025-12-19
Last refreshed	2026-10-29
Market cap	CAD 3.4M
Next earnings date	2026-12-18
Price	CAD 0.02
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-29
Symbol	tsxv/QPT
Website	https://www.questpharmatech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	143.7%
EV/Earnings	0.88x
EV/EBIT	2.36x
FCF / EV yield	-0.24%
FCF yield	-0.31%
Graham number	0.32012
Graham upside	1,500.6%
Lynch fair value	CAD 0.14
Lynch upside	618.5%
P/B ratio	0.13x
P/E ratio	0.7x
Price / tangible book value	0.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-1.66%
ROA (5Y)	-1.68%
ROCE	-2.55%
ROE	19.95%
ROE (5Y)	-35.07%
ROIC	-1.68%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (QoQ)	0%
EPS growth 5Y	-42.94%
FCF growth (Q)	0.28%
FCF growth (QoQ)	0%
Net income growth (QoQ)	0%
Net income growth 5Y	-42.98%
OCF growth (Q)	0.28%
OCF growth (QoQ)	0%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
EBIT	CAD -683,044
EPS	CAD 0.03
FCF per share	CAD -0.00
Free cash flow	CAD -10,395
Free cash flow minus SBC	CAD -90,395
Net cash flow	CAD -10,395
Net income	CAD 4.9M
Operating cash flow minus SBC	CAD -90,395
Operating income	CAD -683,044
Stock-based compensation	CAD 80,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CAD 0.16
Debt / equity	0.04
Interest coverage	-33.74
Long-term assets	CAD 28.2M
Long-term liabilities	CAD 0
Net cash (debt)	CAD -917,155
Net cash / market cap	-27.11%
Net debt / equity	0.03
Piotroski F-Score	1
Shareholders' equity	CAD 26.8M
Tangible book value	CAD 26.8M
Tangible book value per share	CAD 0.16
Total assets	CAD 28.3M
Total cash	CAD 82,845
Total debt	CAD 1M
Total liabilities	CAD 1.5M
WACC	1.68%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CAD 87,474
Current liabilities	CAD 1.5M
Current ratio	0.06
Net working capital	CAD -484,144
Quick ratio	0.06
Working capital	CAD -1.4M

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-60%
10Y return CAGR	-8.76%
10Y total return	-60%
150-day SMA	CAD 0.03
15Y price change	-20%
15Y return CAGR	-1.48%
15Y total return	-20%
1D price change	0%
1M price change	-20%
1M total return	-20%
1Y price change	-50%
1Y return CAGR	-50.02%
1Y total return	-50%
20-day SMA	CAD 0.02
200-day SMA	CAD 0.03
20Y price change	-69.23%
20Y return CAGR	-5.72%
20Y total return	-69.23%
3Y price change	-63.64%
3Y return CAGR	-28.62%
3Y total return	-63.64%
50-day SMA	CAD 0.03
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.05
52-week high date	2025-11-19
52-week low	CAD 0.02
52-week low date	2026-10-20
5Y price change	-75%
5Y return CAGR	-24.22%
5Y total return	-75%
6M price change	-42.86%
6M total return	-42.86%
All-time high	CAD 3.00
All-time high date	2000-03-06
All-time low	CAD 0.02
All-time low date	2008-12-23
Average true range (ATR)	CAD 0.00
Average volume	26.8K
Beta (1Y)	-0.21
Beta (2Y)	-1.73
Beta (5Y)	-0.46
Change from 52-week high	-60%
Change from 52-week low	0%
Change from all-time high	-99.33%
Change from all-time low	33.33%
Change from open	0%
Day's gap	0%
Dollar volume	CAD 40
High price	CAD 0.02
Low price	CAD 0.02
Monthly RSI	40.55
Open price	CAD 0.02
Previous close	CAD 0.02
Price vs 150-day SMA	-40.3%
Price vs 20-day SMA	-10.31%
Price vs 200-day SMA	-42.53%
Price vs 50-day SMA	-30.31%
Relative volume	0.07
RSI	44.09
Sharpe ratio	0.81
Sharpe ratio (3Y)	0.82
Sharpe ratio (5Y)	0.73
Sortino ratio	1.34
Sortino ratio (3Y)	1.37
Sortino ratio (5Y)	1.26
Volume	2K
Weekly RSI	40.38
YTD price change	-42.86%
YTD total return	-42.86%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	138.7M
Shares change (QoQ)	0%
Shares held by insiders	3.18%
Shares outstanding	169.1M

Deeper analysis on TSXV/QPT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSXV/QPT report

Is a complete TSXV/QPT research report available?

No complete published report is available for tsxv/QPT (TSXV/QPT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSXV/QPT (TSXV/QPT)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/QPT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/QPT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Performance and technicals

Ownership and float

Deeper analysis on TSXV/QPT

Frequently asked questions